Cathepsins D, B, and L in malignant human lung tissue

Area of Science:

• Biochemistry
• Oncology
• Molecular Biology

Background:

• Cathepsins are lysosomal proteases involved in various cellular processes.
• Dysregulation of cathepsin activity is implicated in cancer progression.
• Specific cathepsin profiles in non-small cell lung cancer (NSCLC) require further elucidation.

Purpose of the Study:

• To quantify and compare the activity and protein levels of Cathepsin B, L, and D in malignant and non-malignant lung tissues from NSCLC patients.
• To investigate the correlation between cathepsin expression and tumor differentiation and histology.
• To assess the potential diagnostic or prognostic value of cathepsins in NSCLC.

Main Methods:

• Activity assays for Cathepsin B, L, and D using specific substrates.
• Enzyme-linked immunosorbent assays (ELISAs) for quantifying Cathepsin B, L, and D protein concentrations.
• Analysis of 17 non-small cell lung cancer specimens, comparing malignant and adjacent non-malignant tissues.

Main Results:

• Significantly higher activities of Cathepsin B (P < 0.0012) and Cathepsin L (P < 0.0003) were observed in malignant tissues compared to non-malignant tissues.
• Median Cathepsin B protein increased 5.6-fold (P < 0.054) and Cathepsin L protein increased 2.2-fold (P < 0.069) in tumors.
• Cathepsin D concentration and protein levels showed no significant increase in malignant tissues.
• A moderate correlation (r = 0.5, P < 0.045) was found between Cathepsin B and L expression.
• Higher Cathepsin L activity and protein levels were associated with poorly differentiated tumors and adenocarcinoma histology.

Conclusions:

• The three lysosomal enzymes (Cathepsin B, L, and D) are regulated non-coordinately in lung cancer.
• There is specific induction of cysteine cathepsins (Cathepsin B and L) in NSCLC.
• Further studies in larger patient cohorts are needed to determine the diagnostic and prognostic value of Cathepsin B and L in lung cancer.